BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

EMULATE THERAPEUTICS — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Termination

EMULATE THERAPEUTICS

via STRATEGIES 360

4th Quarter (Oct 1 - Dec 31) · 2019Posted Apr 16, 2020Filing document ↗LDA record ↗

Income$30Kfee reported

Client

Name: EMULATE THERAPEUTICS
Description: Clinical-stage therapeutic device company
Location: Washington · United States of America

Registrant

Firm: STRATEGIES 360
Description: Government affairs
Location: Seattle, Washington, United States of America

Lobbying activities

1 issue

Medical/Disease Research/Clinical Labs
Issues related to medical device technology and FDA accelerated pathway
Lobbyistsms TYLYNN R GORDON · CRYSTAL ELLERBE
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.